Union Minister Jitendra Singh on Saturday informed that India has developed its first indigenously discovered antibiotic '

周六，印度联邦部长吉滕德拉·辛格表示，印度已经研发出其首个本土发现的抗生素。

Nafithromycin

那法霉素

', which is effective against

'，对以下内容有效

resistant respiratory infections

耐药性呼吸道感染

, particularly useful for cancer patients and poorly controlled diabetics.

，特别适用于癌症患者和控制不佳的糖尿病患者。

He said this antibiotic is the first molecule entirely conceptualised, developed and clinically validated in India, representing a significant leap toward self-reliance in the pharmaceutical sector.

他说，这种抗生素是印度首个完全自主构思、开发并经过临床验证的分子，标志着制药领域朝着自力更生迈出了重要一步。

According to an official release from the

根据官方发布的消息，

Ministry of Science and Technology

科技部

, the antibiotic Naphithromycin has been developed by the Government of India's

，抗生素Naphithromycin已由印度政府开发。

Department of Biotechnology

生物技术系

in collaboration with the well-known private pharma house

与著名的私人制药公司合作

Wockhardt

沃克哈特

.

。

Citing this as an example of a successful industry-academia partnership driving India's

引用此例为成功推动印度产学研合作的典范

biopharmaceutical growth

生物制药增长

, the Union Minister emphasised the need to build a self-sustainable innovation ecosystem, so that India could reduce its dependence on government funding and create a culture of private sector participation and philanthropic support to achieve global recognition in research and innovation.

，印度联邦部长强调需要建立一个自我可持续的创新生态系统，以此减少印度对政府资金的依赖，创造私营部门参与和慈善支持的文化，从而在全球研究与创新领域获得认可。

Inaugurating the 3-day Medical Workshop on 'Harnessing Artificial Intelligence for Multi-Omics Data Integration and Analysis', Jitendra Singh said that India must develop a self-sustainable ecosystem to drive its scientific and research growth. He stated that most nations that have achieved global recognition in science and innovation have done so through self-sustaining, innovation-driven models with extensive engagement of the private sector..

启动为期3天的“利用人工智能进行多组学数据整合与分析”医学研讨会时，吉滕德拉·辛格表示，印度必须发展一个自我可持续的生态系统，以推动其科学和研究的增长。他指出，大多数在科学和创新领域获得全球认可的国家都是通过自我可持续、创新驱动的模式实现的，并且私营部门的广泛参与起到了重要作用。

Live Events

现场活动

Citing another successful story of government-non-government collaboration, the Minister also announced that India has achieved a major breakthrough in gene therapy, marking the first successful indigenous clinical trial for Haemophilia treatment, the trial for which was supported by the Government of India's Department of Biotechnology and done in a non-government sector hospital, Christian Medical College, Vellore..

引用另一个政府与非政府合作的成功案例，部长还宣布印度在基因治疗方面取得了重大突破，标志着血友病治疗的首次成功本土临床试验，该试验得到了印度政府生物技术部的支持，并在非政府医院——韦洛尔基督教医学院进行。

Singh further mentioned that India has already sequenced over 10,000 human genomes and aims to scale this up to one million. The gene therapy trial, he added, recorded a 60-70% correction rate with zero bleeding episodes, representing a milestone in India's medical research landscape. The findings have been published in the New England Journal of Medicine, underscoring India's growing leadership in advanced biomedical innovation..

辛格进一步提到，印度已经对超过一万个的人类基因组进行了测序，并计划将这一数字增加到一百万。他补充说，基因治疗试验记录了60%-70%的纠正率，且没有出现出血事件，这在印度医学研究领域具有里程碑意义。这些研究成果已发布在《新英格兰医学杂志》上，彰显了印度在先进生物医学创新领域的领导地位日益增强。

Speaking at the occasion, Jitendra Singh said the Anusandhan National Research Foundation (ANRF) is a major step in this direction, with a total outlay of Rs 50,000 crore over five years, of which Rs 36,000 crore will come from non-government sources. This model, he added, reflects a paradigm shift in India's approach to research and development, aligning it with global standards and emphasising greater participation of academia and industry..

在此次活动中发言时，吉滕德拉·辛格表示，阿努桑丹国家研究基金会 (ANRF) 是这一方向上的重要一步，在五年内总投入达 5000 亿卢比，其中 3600 亿卢比将来自非政府来源。他补充道，该模式反映了印度在研发方法上的范式转变，使其与全球标准接轨，并强调学术界和产业界更广泛的参与。

Jitendra Singh highlighted that Artificial Intelligence (AI) has become one of the most transformative tools of the modern era, reshaping healthcare accessibility, governance efficiency, and decision-making. He mentioned that AI-based hybrid mobile clinics are already serving rural and remote regions, ensuring quality healthcare for all.

杰伦德拉·辛格强调，人工智能（AI）已成为现代最具变革性的工具之一，正在重塑医疗可及性、治理效率和决策方式。他提到，基于人工智能的混合移动诊所已经在为农村和偏远地区服务，确保人人享有优质医疗服务。

He also referred to the AI-driven grievance redressal system developed by the Department of Administrative Reforms and Public Grievances (DARPG), which has achieved a weekly disposal rate of 97-98%, significantly improving citizen satisfaction and service delivery..

他还提到了由行政改革和公共申诉部（DARPG）开发的AI驱动的申诉处理系统，该系统实现了每周97-98%的处理率，大幅提高了公民满意度和服务效率。

The Minister lauded institutions like Sir Ganga Ram Hospital for pioneering interdisciplinary approaches by integrating AI, biotechnology and genomics to improve healthcare outcomes. He urged greater collaboration between government departments, private hospitals, and research institutes to realise the vision of Viksit Bharat @2047..

部长赞扬了像Sir Ganga Ram医院这样的机构，因其通过整合人工智能、生物技术和基因组学开创了跨学科方法以改善医疗保健成果。他敦促政府部门、私立医院和研究机构之间加强合作，以实现“2047年发达印度”的愿景。

Jitendra Singh said that India is entering a new era of self-reliance in biotechnology, AI and genomic medicine. The convergence of innovation, collaboration and compassion, he said, will define India's journey toward a developed nation and establish its leadership in the global science and technology landscape..

吉滕德拉·辛格表示，印度正在进入生物技术、人工智能和基因组医学自力更生的新时代。他说，创新、合作和同情心的融合将定义印度迈向发达国家的旅程，并确立其在全球科技领域的领导地位。

The event was also attended by Shiv Kumar Kalyanaraman, CEO of Anusandhan National Research Foundation, NK Ganguly, DS Rana, and Ajay Swaroop.

该活动还迎来了阿努桑德翰国家研究基金会首席执行官希夫·库马尔·卡利亚纳拉曼、NK甘古利、DS拉纳和阿贾伊·斯瓦鲁普的出席。

Add

添加

as a Reliable and Trusted News Source

作为可靠和值得信赖的新闻来源

Add Now!

立即添加！

(You can now subscribe to our

（您现在可以订阅我们的

Economic Times WhatsApp channel

经济时报 WhatsApp 频道

)

)

(You can now subscribe to our

（您现在可以订阅我们的

Economic Times WhatsApp channel

经济时报 WhatsApp 频道

)

)